- Home
- MMTX vs BSEM Comparison
MMTX vs BSEM Comparison
Compare MMTX & BSEM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MMTX | BSEM |
|---|---|---|
| Founded | 2025 | 2006 |
| Country | Taiwan | United States |
| Employees | N/A | N/A |
| Industry | Blank Checks | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 90.1M | 76.9M |
| IPO Year | 2025 | 2026 |
Fundamental Metrics
Financial Performance| Metric | MMTX | BSEM |
|---|---|---|
| Price | $10.28 | $1.06 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 56.7K | ★ 161.9K |
| Earning Date | 01-01-0001 | 11-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $87.68 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $9.89 | $1.04 |
| 52 Week High | $10.28 | $5.44 |
Technical Indicators
Market Signals| Indicator | MMTX | BSEM |
|---|---|---|
| Relative Strength Index (RSI) | 70.63 | 23.71 |
| Support Level | $10.14 | N/A |
| Resistance Level | N/A | $4.65 |
| Average True Range (ATR) | 0.01 | 0.18 |
| MACD | 0.00 | 0.02 |
| Stochastic Oscillator | 100.00 | 9.10 |
Price Performance
Historical ComparisonAbout MMTX Miluna Acquisition Corp Class A Ordinary Share
Miluna Acquisition Corp is a blank check company.
About BSEM BioStem Technologies Inc. Common Stock
BioStem Technologies Inc is a regenerative biotechnology company focused on harnessing elements of perinatal tissue and the body's innate biology to repair or reverse damage caused by a broad range of degenerative diseases. The company develops, manufactures, and sells tissue allografts for the wound care market with a focus on the treatment of diabetic, pressure, and venous ulcers. Utilizing its proprietary BioRetain processing method, it manufactures perinatal tissue allografts. The company offers a comprehensive portfolio of high-quality brands that are trademarked and include VENDAJE AC, AmnioWrap2, and Others. The company generates key revenue from VENDAJE AC.